8114 — Posiflex Technology Balance Sheet
0.000.00%
Last trade - 00:00
- TWD8.73bn
- TWD14.41bn
- TWD9.87bn
- 74
- 68
- 59
- 81
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,216 | 2,433 | 2,086 | 2,781 | 3,130 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,542 | 1,340 | 1,760 | 1,718 | 1,302 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 5,831 | 5,946 | 7,125 | 8,434 | 7,135 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4,397 | 4,121 | 4,008 | 3,609 | 3,577 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 14,205 | 13,829 | 14,785 | 15,798 | 14,864 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,447 | 4,020 | 3,675 | 3,554 | 3,208 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 11,363 | 11,341 | 11,956 | 12,042 | 11,247 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 2,842 | 2,488 | 2,829 | 3,756 | 3,616 |
Total Liabilities & Shareholders' Equity | 14,205 | 13,829 | 14,785 | 15,798 | 14,864 |
Total Common Shares Outstanding |